Omrix Biopharmaceuticals, Inc. (NASDAQ:OMRI.DL)
CAPS Rating:
A commercial-stage biopharmaceutical company that develops and markets innovative biological products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked OMRI.DL yet. Tell us why you think OMRI.DL will outperform or underperform the market.
RSS Headlines
Fool UK
